Current Paediatrics
Volume 13, Issue 5 , Pages 327-334, October 2003

The outcome of juvenile idiopathic arthritis

  • Boel Andersson Gäre

      Affiliations

    • Physician-in-Chief, Department of Paediatrics, Ryhov County Hospital, SE-Jőnkőping, Sweden
  • ,
  • Anders Fasth

      Affiliations

    • Professor of Paediatric Immunology, Department of Paediatrics, Gőteborg University and Head, Division of Paediatric Immunology, The Queen Silvia Children's Hospital, SE-416 85 Gothenburg, Sweden
    • Corresponding Author InformationCorrespondence to: AF. Tel.: +46-31-343-5220; fax: +46-31-843-010

Abstract 

To evaluate outcome studies for childhood arthritides, we need to consider the heterogeneity of the disease, the criteria used to define the condition and how the population investigated was chosen. In this review, population- and hospital-based studies from the last 10 years were analysed. Due to the heterogeneity, continuing disease activity varied between 39 and 67% for all subgroups with the best prognosis for persistent oligoarthritis. Disability measured by CHAQ/HAQ showed that at least one-third of patients report some impact of the disease, but severe disability was rare. Many studies also report lower quality of life in patients compared with controls. Risk factors for disability were female sex, a polyarticular disease course and positive IgM rheumatoid factor.

In summary, juvenile idiopathic arthritis is both a self-limiting disease and a progressive disease, which creates disability and decreased quality of life. There seem to be differences in the quality of life and participation in society between nations, and further studies from different parts of the world are necessary. This research should include the perspective of patients and their families.

Keywords:  arthritis, juvenile rheumatoid, disease activity, disability, prognosis, outcome

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0957-5839(03)00061-7

doi:10.1016/S0957-5839(03)00061-7

Current Paediatrics
Volume 13, Issue 5 , Pages 327-334, October 2003